These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
608 related articles for article (PubMed ID: 35658829)
1. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis. Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829 [TBL] [Abstract][Full Text] [Related]
2. Activation of PI3K/AKT/mTOR signaling axis by UBE2S inhibits autophagy leading to cisplatin resistance in ovarian cancer. Zhang M; Wang J; Guo Y; Yue H; Zhang L J Ovarian Res; 2023 Dec; 16(1):240. PubMed ID: 38115063 [TBL] [Abstract][Full Text] [Related]
3. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition. Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796 [TBL] [Abstract][Full Text] [Related]
4. NUF2 promotes tumorigenesis by interacting with HNRNPA2B1 via PI3K/AKT/mTOR pathway in ovarian cancer. Ren M; Zhao H; Gao Y; Chen Q; Zhao X; Yue W J Ovarian Res; 2023 Jan; 16(1):17. PubMed ID: 36670423 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway. Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851 [TBL] [Abstract][Full Text] [Related]
6. Fuzheng Jiedu Decoction Induces Apoptosis and Enhances Cisplatin Efficacy in Ovarian Cancer Cells Yang H; Li H; Lu S; Shan S; Guo Y Biomed Res Int; 2022; 2022():5739909. PubMed ID: 35281608 [TBL] [Abstract][Full Text] [Related]
7. Knockdown of Hypoxia-Inducible Factor 1α (HIF-1α) Promotes Autophagy and Inhibits Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Ovarian Cancer Cells. Huang J; Gao L; Li B; Liu C; Hong S; Min J; Hong L Med Sci Monit; 2019 Jun; 25():4250-4263. PubMed ID: 31175269 [TBL] [Abstract][Full Text] [Related]
8. Endoplasmic reticulum stress regulates proliferation, migration and invasion of human ovarian cancer SKOV3 cells through PI3K/AKT/mTOR signaling pathway. Yang N; Qu YJ; Cheng Y; Liang T; Zhang MN; Zhang D; Dong LN; Wang XW; Zhang GM Cancer Biomark; 2017 Jul; 19(3):263-269. PubMed ID: 28453460 [TBL] [Abstract][Full Text] [Related]
9. The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines. Bai H; Li H; Li W; Gui T; Yang J; Cao D; Shen K Oncotarget; 2015 Sep; 6(28):25520-32. PubMed ID: 26267321 [TBL] [Abstract][Full Text] [Related]
10. TCP1 regulates PI3K/AKT/mTOR signaling pathway to promote proliferation of ovarian cancer cells. Weng H; Feng X; Lan Y; Zheng Z J Ovarian Res; 2021 Jun; 14(1):82. PubMed ID: 34162426 [TBL] [Abstract][Full Text] [Related]
11. Autophagy-related gene PXN as a prognostic marker: Promotion of ovarian cancer progression by suppressing the p110β/Vps34/Beclin1 pathway. Wu Q; Cui Z; Jiang S; Xia H; Liu L; You Y; Sun Y Cell Biochem Funct; 2023 Jul; 41(5):599-608. PubMed ID: 37232085 [TBL] [Abstract][Full Text] [Related]
12. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway. Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014 [TBL] [Abstract][Full Text] [Related]
13. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway. Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X Gene; 2019 May; 698():50-60. PubMed ID: 30822475 [TBL] [Abstract][Full Text] [Related]
14. Effect of STK3 on proliferation and apoptosis of pancreatic cancer cells via PI3K/AKT/mTOR pathway. Chen J; Liu F; Wu J; Yang Y; He J; Wu F; Yang K; Li J; Jiang Z; Jiang Z Cell Signal; 2023 Jun; 106():110642. PubMed ID: 36871796 [TBL] [Abstract][Full Text] [Related]
15. Betulin terpenoid targets OVCAR-3 human ovarian carcinoma cells by inducing mitochondrial mediated apoptosis, G2/M phase cell cycle arrest, inhibition of cell migration and invasion and modulating mTOR/PI3K/AKT signalling pathway. Yang Q; Fei Z; Huang C Cell Mol Biol (Noisy-le-grand); 2021 Sep; 67(2):14-19. PubMed ID: 34817343 [TBL] [Abstract][Full Text] [Related]
16. PLAUR facilitates the progression of clear cell renal cell carcinoma by activating the PI3K/AKT/mTOR signaling pathway. Qin T; Huang M; Wei W; Zhou W; Tang Q; Huang Q; Tang N; Gai S PeerJ; 2024; 12():e17555. PubMed ID: 38948215 [TBL] [Abstract][Full Text] [Related]
17. Anhuienoside C inhibits human ovarian cancer cell growth by inducing apoptosis, suppression of cell migration and invasion, and targeting PI3K/AKT/mTOR signaling pathway. Zhu Y; Yang L; Chen Y Mol Cell Biochem; 2022 Jul; 477(7):1887-1892. PubMed ID: 35348981 [TBL] [Abstract][Full Text] [Related]
18. Protein kinase C iota promotes glycolysis via PI3K/AKT/mTOR signalling in high grade serous ovarian cancer. Tyagi K; Roy A; Mandal S Mol Biol Rep; 2024 Sep; 51(1):983. PubMed ID: 39276277 [TBL] [Abstract][Full Text] [Related]
19. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway. Xie Z; Li W; Ai J; Xie J; Zhang X J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661 [TBL] [Abstract][Full Text] [Related]
20. FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway. Zhu H; Diao S; Lim V; Hu L; Hu J Acta Biochim Biophys Sin (Shanghai); 2019 May; 51(5):509-516. PubMed ID: 30939187 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]